Achelios to present TOPOFEN™ Results

Achelios Therapeutics to present results of Phase 1b-2a  TOPOFEN™ migraine study at American Academy of Neurology Session on Emerging Science on April 22. TOPOFEN™, a new topical medication for the treatment of acute migraine. Achelios Therapeutics (privately held, Chapel Hill, NC) today announced results from a Phase IIa placebo-controlled clinical trial in moderate and severe […]

What Symptoms Occur During a Migraine Attack? Migraineurs have recurrent, severe, and disabling attacks of headache, often unilateral and pulsating, along with symptoms of sensory disturbance, such as light, sound, and odor sensitivity. Nausea and neck stiffness are other common symptoms, and symptoms can be aggravated by movement. Some patients experience dizziness during attacks. About […]